TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Polydatin, Brusatol
Phytochemical Name Polydatin (PubChem CID: 5281718 )
Anticancer drug Name Brusatol (PubChem CID: 73432 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 807
Pair Name Polydatin, Brusatol
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Gene Regulation Down-regulation Expression HMOX1 hsa3162
Down-regulation Expression NFE2L2 hsa4780
Down-regulation Expression NQO1 hsa1728
In Vitro Model MDA-MB-231 Breast adenocarcinoma Homo sapiens (Human) CVCL_0062
SUM159PT Breast pleomorphic carcinoma Homo sapiens (Human) CVCL_5423
In Vivo Model MDA-MB-231 (100 μL containing 5×10⁶ cells) were injected subcutaneously into nude mice. Until the tumor volume reached 100–200 mm3, mice in the individual administration groups were injected intraperitoneally with PD 50 mg/kg, the combined administration group was PD 25 mg/kg and BRU 1 mg/kg.
Result We could significantly reduce tumor cell growth while avoiding toxic side effects, providing a treatment method with greater clinical application value for TNBC treatment.
03. Reference
No. Title Href
1 Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway. Int J Mol Sci. 2023 May 5;24(9):8265. doi: 10.3390/ijms24098265. Click
It has been 58803 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP